The Embrace2, a seizure monitoring wearable from Boston and Milan-based Embrace, has received an updated FDA clearance that allows it to be used by children ages six and up — the first such device to ...
LONDON--(BUSINESS WIRE)-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that 24-month data on generalized tonic-clonic (GTC) seizures in people with ...
Hosted on MSN
The Medicine Cabinet: Ask the Harvard Experts: How to respond when witnessing a seizure
Q: When I was in the grocery store last week, a person close to me had a full-blown seizure. No one knew what to do. How should observers respond to the situation? A: It sounds like this person had a ...
The first seizure clinic model enabled rapid diagnosis and treatment for children with epilepsy, according to data presented ...
CLEVELAND — November marks National Epilepsy Awareness Month, drawing attention to a neurological condition that affects almost 3 million adults and nearly half a million children across the United ...
SK Biopharmaceutical’s Xcopri (cenobamate) met the bar in a phase 3 trial that could support the company’s ambitions of building a blockbuster with an expansion into another seizures subtype. Now, ...
Epilepsy is a common neurological disorder that affects millions of people worldwide. Characterized primarily by seizures, epilepsy can present in a variety of ways depending on the individual and the ...
About 60-70% of focal epilepsy patients achieve seizure control with first-line antiseizure medications (ASMs). Lamotrigine and levetiracetam demonstrate high efficacy and tolerability for seizure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback